Bioblast Pharma Ltd.
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Treatment of Oculopharyngeal Muscular Dystrophy With Trehalose (NCT04226924) | Bioblast Pharma Ltd. | 2017-06-15 |
| A Study to Establish Safety and Maximum Tolerated Dose of IV Trehalose in Healthy Subjects (NCT02725957) | Bioblast Pharma Ltd. | 2016-03-01 |
| Continuation Protocol to Protocol BBCO-001 (NCT02328482) | Bioblast Pharma Ltd. | 2015-01-01 |
| Study To Assess Safety, Tolerability and Efficacy of Intravenous Cabaletta in Patients With Machado-Joseph Disease (NCT02147886) | Bioblast Pharma Ltd. | 2014-07-01 |
| Safety Tolerability and Efficacy Study of Cabaletta to Treat Oculopharyngeal Muscular Dystrophy (OPMD) Patients (NCT02015481) | Bioblast Pharma Ltd. | 2014-02-01 |
Track Bioblast Pharma Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.